These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32054355)

  • 21. Management of women with PCOS using myo-inositol and folic acid. New clinical data and review of the literature.
    Regidor PA; Schindler AE; Lesoine B; Druckman R
    Horm Mol Biol Clin Investig; 2018 Mar; 34(2):. PubMed ID: 29498933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS).
    Fruzzetti F; Perini D; Russo M; Bucci F; Gadducci A
    Gynecol Endocrinol; 2017 Jan; 33(1):39-42. PubMed ID: 27808588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of myo-inositol and metformin on clinical, metabolic and genetic parameters in polycystic ovary syndrome: A randomized controlled clinical trial.
    Jamilian M; Farhat P; Foroozanfard F; Afshar Ebrahimi F; Aghadavod E; Bahmani F; Badehnoosh B; Jamilian H; Asemi Z
    Clin Endocrinol (Oxf); 2017 Aug; 87(2):194-200. PubMed ID: 28485095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial.
    Costantino D; Minozzi G; Minozzi E; Guaraldi C
    Eur Rev Med Pharmacol Sci; 2009; 13(2):105-10. PubMed ID: 19499845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. d-chiro-Inositol and alpha lipoic acid treatment of metabolic and menses disorders in women with PCOS.
    Cianci A; Panella M; Fichera M; Falduzzi C; Bartolo M; Caruso S
    Gynecol Endocrinol; 2015 Jun; 31(6):483-6. PubMed ID: 25893270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized, double blind placebo-controlled trial: effects of myo-inositol on ovarian function and metabolic factors in women with PCOS.
    Gerli S; Papaleo E; Ferrari A; Di Renzo GC
    Eur Rev Med Pharmacol Sci; 2007; 11(5):347-54. PubMed ID: 18074942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS.
    Pizzo A; Laganà AS; Barbaro L
    Gynecol Endocrinol; 2014 Mar; 30(3):205-8. PubMed ID: 24351072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Combined therapy myo-inositol plus D-Chiro-inositol, in a physiological ratio, reduces the cardiovascular risk by improving the lipid profile in PCOS patients.
    Minozzi M; Nordio M; Pajalich R
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17(4):537-40. PubMed ID: 23467955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Predictive Role of Serum Cystatin C Levels in Polycystic Ovary Syndrome in Adolescents.
    Çınar M; Aksoy RT; Güzel Aİ; Tokmak A; Çandar T; Taşçı Y
    J Pediatr Adolesc Gynecol; 2016 Aug; 29(4):353-6. PubMed ID: 26740281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The value of anti-Mullerian hormone in the management of polycystic ovary syndrome in adolescents.
    Asanidze E; Kristesashvili J; Pkhaladze L; Khomasuridze A
    Gynecol Endocrinol; 2019 Nov; 35(11):974-977. PubMed ID: 31116610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myo-inositol modulates insulin and luteinizing hormone secretion in normal weight patients with polycystic ovary syndrome.
    Genazzani AD; Santagni S; Ricchieri F; Campedelli A; Rattighieri E; Chierchia E; Marini G; Despini G; Prati A; Simoncini T
    J Obstet Gynaecol Res; 2014 May; 40(5):1353-60. PubMed ID: 24606639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.
    Koo YA; Shin SY; Yoon BK; Choi D
    Gynecol Endocrinol; 2007; 23(8):461-7. PubMed ID: 17852414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ovulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients with insulin resistance.
    Kamenov Z; Kolarov G; Gateva A; Carlomagno G; Genazzani AD
    Gynecol Endocrinol; 2015 Feb; 31(2):131-5. PubMed ID: 25259724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of ovarian function and metabolic factors in women affected by polycystic ovary syndrome after treatment with D-Chiro-Inositol.
    Laganà AS; Barbaro L; Pizzo A
    Arch Gynecol Obstet; 2015 May; 291(5):1181-6. PubMed ID: 25416201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
    Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
    Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of sequential administration of octreotide alone and octreotide/growth hormone simultaneously on buserelin stimulated ovarian steroid secretion in women with polycystic ovary syndrome.
    Piaditis GP; Hatziioanidis AH; Trovas GP; Misichronis GS; Kounadi TG; Devetzaki OA; Andronis CK; Rangou DB; Chlouverakis CS
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):595-604. PubMed ID: 8977757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of myo-inositol and metformin on glycemic control, lipid profiles, and gene expression related to insulin and lipid metabolism in women with polycystic ovary syndrome: a randomized controlled clinical trial.
    Shokrpour M; Foroozanfard F; Afshar Ebrahimi F; Vahedpoor Z; Aghadavod E; Ghaderi A; Asemi Z
    Gynecol Endocrinol; 2019 May; 35(5):406-411. PubMed ID: 30608001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients.
    Genazzani AD; Shefer K; Della Casa D; Prati A; Napolitano A; Manzo A; Despini G; Simoncini T
    J Endocrinol Invest; 2018 May; 41(5):583-590. PubMed ID: 29090431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of combination therapy of inositols, antioxidants and vitamins in obese and non-obese women with polycystic ovary syndrome: an observational study.
    Advani K; Batra M; Tajpuriya S; Gupta R; Saraswat A; Nagar HD; Makwana L; Kshirsagar S; Kaul P; Ghosh AK; Pradhan S; Mehta A; Jaiswal A; Nakhate KT; Kamdi S
    J Obstet Gynaecol; 2020 Jan; 40(1):96-101. PubMed ID: 31339394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and metabolic characteristics of Turkish adolescents with polycystic ovary syndrome.
    Ates S; Aydın S; Ozcan P; Soyman Z; Gokmen Karasu AF; Sevket O
    J Obstet Gynaecol; 2018 Feb; 38(2):236-240. PubMed ID: 28920502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.